164 related articles for article (PubMed ID: 30705401)
1. PKCζ facilitates lymphatic metastatic spread of prostate cancer cells in a mice xenograft model.
Zang G; Mu Y; Gao L; Bergh A; Landström M
Oncogene; 2019 May; 38(22):4215-4231. PubMed ID: 30705401
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CCAT1/miR-148a/PKCζ prevents cell migration of prostate cancer by altering macrophage polarization.
Liu J; Ding D; Jiang Z; Du T; Liu J; Kong Z
Prostate; 2019 Jan; 79(1):105-112. PubMed ID: 30221381
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of cystathionine γ-lyase promotes prostate cancer progression and metastasis.
Wang YH; Huang JT; Chen WL; Wang RH; Kao MC; Pan YR; Chan SH; Tsai KW; Kung HJ; Lin KT; Wang LH
EMBO Rep; 2019 Oct; 20(10):e45986. PubMed ID: 31468690
[TBL] [Abstract][Full Text] [Related]
7. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
8. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
Hou Q; Chen S; An Q; Li B; Fu Y; Luo Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299365
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of atypical protein kinase C‑ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade.
Apostolatos AH; Ratnayake WS; Win-Piazza H; Apostolatos CA; Smalley T; Kang L; Salup R; Hill R; Acevedo-Duncan M
Int J Oncol; 2018 Nov; 53(5):1836-1846. PubMed ID: 30226591
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
[TBL] [Abstract][Full Text] [Related]
13. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
[TBL] [Abstract][Full Text] [Related]
14. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.
Burton JB; Priceman SJ; Sung JL; Brakenhielm E; An DS; Pytowski B; Alitalo K; Wu L
Cancer Res; 2008 Oct; 68(19):7828-37. PubMed ID: 18829538
[TBL] [Abstract][Full Text] [Related]
15. Interaction of tumor cells and lymphatic vessels in cancer progression.
Alitalo A; Detmar M
Oncogene; 2012 Oct; 31(42):4499-508. PubMed ID: 22179834
[TBL] [Abstract][Full Text] [Related]
16. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
17. CD151 is associated with prostate cancer cell invasion and lymphangiogenesis in vivo.
Detchokul S; Newell B; Williams ED; Frauman AG
Oncol Rep; 2014 Jan; 31(1):241-7. PubMed ID: 24174171
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma.
Oliveira-Ferrer L; Milde-Langosch K; Eylmann K; Rossberg M; Müller V; Schmalfeldt B; Witzel I; Wellbrock J; Fiedler W
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963450
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Macrophages Extend Along Lymphatic Flow in the Pre-metastatic Lymph Nodes of Human Gastric Cancer.
Go Y; Tanaka H; Tokumoto M; Sakurai K; Toyokawa T; Kubo N; Muguruma K; Maeda K; Ohira M; Hirakawa K
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S230-5. PubMed ID: 25743331
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis.
Lee AS; Kim DH; Lee JE; Jung YJ; Kang KP; Lee S; Park SK; Kwak JY; Lee SY; Lim ST; Sung MJ; Yoon SR; Kim W
Cancer Res; 2011 Jul; 71(13):4506-17. PubMed ID: 21586615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]